Table 4: Analysis of association of polymorphisms according to the metabolic syndrome component - Hyperglycemia (n = 72). Extended Wester Region of Minas Gerais, MG, Brazil, 2015.
Polymorphism | Without Hyperglycemia | With Hyperglycemia | p* | ||
N | % | N | % | ||
TaqIA genotypes | |||||
Homozygous for C allele | 15 | 62.5 | 22 | 45.8 | 0.084 |
Heterozygous | 6 | 25.0 | 24 | 50.0 | |
Homozygous for T allele | 3 | 12.5 | 2 | 4.2 | |
TaqIA alleles | |||||
W | 36 | 75.0 | 68 | 70.8 | 0.554 |
T | 12 | 25.0 | 28 | 29.2 | |
-141C genotypes | |||||
Homozygous for C allele | 15 | 62.5 | 34 | 70.8 | 0.098 |
Heterozygous | 9 | 37.5 | 9 | 18.8 | |
Homozygous for Ins C allele | 0 | 0 | 5 | 10.4 | |
-141C alleles | |||||
Del C | 39 | 81.3 | 77 | 80.2 | 0.776 |
Ins C | 9 | 18.8 | 19 | 19.8 | |
rs6280 genotypes | |||||
Homozygous for T allele | 13 | 54.2 | 12 | 25.0 | 0.040 |
Heterozygous | 6 | 25.0 | 24 | 50.0 | |
Homozygous for C allele | 5 | 20.8 | 12 | 25.0 | |
rs6280 alleles | |||||
W | 16 | 33.3 | 48 | 50.0 | 0.021 |
T | 32 | 66.7 | 48 | 50.0 |
*χ² Test; significance level: p <0.05.